Dermapharm Holding SE

Dermapharm Holding SE

DMPHF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.92B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Dermapharm Holding SEDermapharm Holding SE142.5%23%1.72
$58.17

Current Fair Value

49.8% upside

Undervalued by 49.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.92 Billion
Enterprise Value$2.92 Billion
Annual dividend$1.01
Dividend yield2.50%
Earnings per Share$2.46
Beta0.85
Outstanding Shares49,540,810

Return

Return on Equity23.28%ROE
Return on Assets6.04%
Return on Invested Capital13.96%

Valuation & Multiples

P/E Ratio14.04P/E Ratio
PEG-35.66PEG
Price to Sales1.69Price to Sales
Price to Book Ratio3.53Price to Book Ratio
Enterprise Value to Revenue2.48
Enterprise Value to EBIT11.83
Enterprise Value to Net Income22
Total Debt to Enterprise0.38
Debt to Equity1.99Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
$0.59
Reported
Revenue
$332.38 M
Est. $345.52 M

Next Earnings Call

Expected Date
April 14, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
$335.35 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Dermapharm Holding SE

3,619 employees
CEO: Hans-Georg Feldmeier

Dermapharm Holding SE, alongside its group companies, specializes in the off-patent branded pharmaceutical market, serving both German and international clients. The company’s operations are organized into three primary divisions: Brande...